Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery system

Drug Design, Development and Therapy

Volumn 7, Issue , 2013, Pages 1015-1026

  Dorniani, Dena ^a   Hussein, Mohd Zobir Bin ^a   Kura, Aminu Umar ^a   Fakurazi, Sharida ^a   Shaari, Abdul Halim ^a   Ahmad, Zalinah ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

6 mercaptopurine; Controlled release; Cytotoxicity; Drug delivery; Superparamagnetic nanoparticles

Indexed keywords

CHITOSAN; MERCAPTOPURINE; NANOCOMPOSITE; SOLVENT; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANIMAL CELL; ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG SYNTHESIS; FIBROBLAST; INFRARED SPECTROSCOPY; MAGNETISM; MATERIAL COATING; MOUSE; NONHUMAN; PARTICLE SIZE; PH; PRECIPITATION; SUSTAINED DRUG RELEASE; THERMOGRAVIMETRY; THERMOSTABILITY; X RAY DIFFRACTION;

6-MERCAPTOPURINE; CONTROLLED RELEASE; CYTOTOXICITY; DRUG DELIVERY; SUPERPARAMAGNETIC NANOPARTICLES;

3T3 CELLS; 6-MERCAPTOPURINE; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CELL LINE, TUMOR; CHITOSAN; DRUG DELIVERY SYSTEMS; FIBROBLASTS; HYDROGEN-ION CONCENTRATION; MAGNETITE NANOPARTICLES; MICE; PARTICLE SIZE; SOLVENTS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; THERMOGRAVIMETRY; TIME FACTORS;

EID: 84884557123     PISSN: 11778881     EISSN: None     Source Type: Journal    
DOI: 10.2147/DDDT.S43035     Document Type: Article

References (47)

1. Zhu L, Ma J, Jia N, Zhao Y, Shen H. Chitosan-coated magnetic nano-particles as carriers of 5-fuorouracil: preparation, characterization and cytotoxicity studies. Colloids Surf B Biointerfaces. 2009;68(1):1-6.
2. Selvaraj V, Alagar M, Hamerton I. Analytical detection and biological assay of antileukemic drug using gold nanoparticles. Electrochim Acta. 2006;52(3):1152-1160.
3. Faridi-Majidi R, Sharif-Sanjani N, Agend F. Encapsulation of magnetic nanoparticles with polystyrene via emulsifer-free miniemulsion polymerization. Thin Solid Films. 2006;515(1):368-374.
4. Zhao Y, Qiu Z, Huang J. Preparation and analysis of Fe3O4 magnetic nanoparticles used as targeted-drug carriers. Chinese J Chem Eng. 2008;16(3):451-455.
5. Mudshinge SR, Deore AB, Patil S, Bhalgat CM. Nanoparticles: emerging carriers for drug delivery. Saudi Pharm J. 2011;19(3):129-141.
6. Xu H, Song T, Bao X, Hu L. Site-directed research of magnetic nanoparticles in magnetic drug targeting. J Magn Magn Mater. 2005;293(1):514-519.
7. Zhang J, Lan CQ, Post M, Simard B, Deslandes Y, Hsieh TH. Design of nanoparticles as drug carriers for cancer therapy. Cancer Genomics Proteomics. 2006;3(3-4):147-157.
8. Hejazi R, Amiji M. Chitosan-based gastrointestinal delivery systems. J Control Release. 2003;89(2):151-165.
9. Amidi M, Romeijn SG, Borchard G, Junginger HE, Hennink WE, Jiskoot W. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. J Control Release. 2006;111(1):107-116.
10. Kim JH, Kim YS, Park K, et al. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. J Control Release. 2008;127(1):41-49.
11. Sang Yo o H, Eun Lee J, Chung H, Chan Kwon I, Young Jeong S. Self-assembled nanoparticles containing hydrophobically modifed glycol chitosan for gene delivery. J Control Release. 2005;103(1):235-243.
12. Mao C, Zhu JJ, Hu YF, et al. Surface modification using photocross-linkable chitosan for improving hemocompatibility. Colloids Surf B Biointerfaces. 2004;38(1):47-53.
13. Tidd DM, Paterson ARP. A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine. Cancer Res. 1974;34(4):738-746.
14. Nerstroem VM, Henriksen U, Nielsen PE, Buchardt O, Schmiegelow K, Koch C. Monoclonal antibodies to thioguanine: influence of coupling position on fine specificity. Bioconjug Chem. 1994;5(4):357-363.
15. Sorouraddin MH, Khani M Y, Amini K, Naseri A, Asgari D, Rashidi MR. Simultaneous determination of 6-mercaptopurine and its oxidative metabolites in synthetic solutions and human plasma using spectrophotometric multivariate calibration methods. Bioimpacts. 2011;1(1):53-62.
16. 2-)] n. J Solid State Chem. 1997;132(1):78-87.
17. Bariyanga J, Luyt AS. Synthesis, Fourier transform infrared, nuclear magnetic resonance and thermal analysis of sodium and platinum complexes of 6-mercaptopurine. J Mol Struct. 2001;559(1): 49-54.
18. Lee HS, Shao H, Huang Y, Kwak BK. Synthesis of MRI contrast agent by coating superparamagnetic iron oxide with chitosan. IEEE Trans Magn. 2005;41(10):4102-4104.
19. Genta I, Perugini P, Pavanetto F. Different molecular weight chitosan microspheres: influence on drug loading and drug release. Drug Dev Ind Pharm. 1998;24(8):779-784.
20. Sinha VR, Singla AK, Wadhawan S, et al. Chitosan microspheres as a potential carrier for drugs. Int J Pharm. 2004;274(1):1-33.
21. Ghotbi MY, bin Hussein MZ. Controlled release study of an anti-carcinogenic agent, gallate from the surface of magnetite nanoparticles. J Phys Chem Solids. 2012;73:936-942.
22. Hassanjani-Roshan A, Vaezi MR, Shokuhfar A, Rajabali Z. Synthesis of iron oxide nanoparticles via sonochemical method and their characterization. Particuology. 2011;9(1):95-99.
23. Su C-C, Yang J-S, Lin S-Y, et al. Curcumin inhibits WEHI-3 leukemia cells in BALB/c mice in vivo. In Vivo. 2008;22(1):63-68.
24. Dorniani D, Hussein MZB, Kura AU, Fakurazi S, Shaari AH, Ahmad Z. Preparation of Fe3O4 magnetic nanoparticles coated with gallic acid for drug delivery. Int J Nanomedicine. 2012;7:5745-5756.
25. Xia SJ, Ni ZM, Xu Q, Hu BX, Hu J. Layered double hydroxides as supports for intercalation and sustained release of antihypertensive drugs. J Solid State Chem. 2008;181(10):2610-2619.
26. Ribeiro C, Arizaga GGC, Wypych F, Sierakowski MR. Nanocomposites coated with xyloglucan for drug delivery: in vitro studies. Int J Pharm. 2009;367(1):204-210.
27. Zhang H, Zou K, Guo S, Duan X. Nanostructural drug-inorganic clay composites: structure, thermal property and in vitro release of captopril-intercalated Mg-Al-layered double hydroxides. J Solid State Chem. 2006;179(6):1792-1801.
28. Zhang B, Wang D F, Li HY, Xu Y, Zhang L. Preparation and properties of chitosan-soybean trypsin inhibitor blend film with anti-Aspergillus favus activity. Ind Crop Prod. 2009;29(2):541-548.
29. Costa-Júnior ES, Barbosa-Stancioli E F, Mansur AAP, Vasconcelos WL, Mansur HS. Preparation and characterization of chitosan/poly (vinyl alcohol) chemically crosslinked blends for biomedical applications. Carbohydr Polym. 2009;76(3):472-481.
30. Fan M, Hu Q, Shen K. Preparation and structure of chitosan soluble in wide pH range. Carbohydr Polym. 2009;78(1):66-71.
31. Nidhin M, Indumathy R, Sreeram KJ, Nair BU. Synthesis of iron oxide nanoparticles of narrow size distribution on polysaccharide templates. Bull Mater Sci. 2008;31(1):93-96.
32. Ma H, Qi X, Maitani Y, Nagai T. Preparation and characterization of superparamagnetic iron oxide nanoparticles stabilized by alginate. Int J Pharm. 2007;333(1):177-186.
33. Chaparadza A, Rananavare SB, Shutthanandan V. Synthesis and characterization of lithium-doped tin dioxide nanocrystalline powders. Mater Chem Phys. 2007;102(2):176-180.
34. Yasin Y, Ismail NM, Hussein MZ, Aminudin N. Synthesis and characterization of lawsone-intercalated ZnAl layered double hydroxides. J Biomed Nanotechnol. 2011;7(3):486-488.
35. Bajaj B, Malhotra BD, Choi S. Preparation and characterization of bio-functionalized iron oxide nanoparticles for biomedical application. Thin Solid Films. 2010;519(3):1219-1223.
36. Ge Y, Zhang Y, Xia J, et al. Effect of surface charge and agglomerate degree of magnetic iron oxide nanoparticles on KB cellular uptake in vitro. Colloids Surf B Biointerfaces. 2009;73(2):294-301.
37. Qu JB, Shao H, Jing GL, Huang F. PEG-chitosan-coated iron oxide nanoparticles with high saturated magnetization as carriers of 10-hydroxycamptothecin: preparation, characterization and cytotoxicity studies. Colloids Surf B Biointerfaces. 2013;102: 37-44.
38. Ambrogi V, Fardella G, Grandolini G, Perioli L, Tiralti MC. Intercalation compounds of hydrotalcite-like anionic clays with anti-infammatory agents, II: uptake of diclofenac for a controlled release formulation. AAPS PharmSciTech. 2002;3(3):77-82.
39. Al Ali SHH, Al-Qubaisi M, Hussein MZ, Ismail M, Zainal Z, Hakim MN. Comparative study of Mg/Al-and Zn/Al-layered double hydroxide-perindopril erbumine nanocomposites for inhibition of angiotensin-converting enzyme. Int J Nanomedicine. 2002;7:4251-4262.
40. Zhang H, Zou K, Sun H, Duan X. A magnetic organic-inorganic composite: synthesis and characterization of magnetic 5-aminosalicylic acid intercalated layered double hydroxides. J Solid State Chem. 2005;178(11):3485-3493.
41. Khan AI, O'Hare D. Intercalation chemistry of layered double hydroxides: recent developments and applications. J Mater Chem. 2002;12(11): 3191-3198.
42. Hussein-Al-Ali SH, Al-Qubaisi M, Hussein MZ, Ismail M, Zainal Z, Hakim MN. In vitro inhibition of histamine release behavior of cetirizine intercalated into zn/al-and mg/al-layered double hydroxides. Int J Mol Sci. 2002;13(5):5899-5916.
43. Dong L, Yan L, Hou WG, Liu SJ. Synthesis and release behavior of composites of camptothecin and layered double hydroxide. J Solid State Chem. 2010;183(8):1811-1816.
44. Ho YS, Ofomaja AE. Pseudo-second-order model for lead ion sorption from aqueous solutions onto palm kernel fber. J Hazard Mater. 2006;129(1):137-142.
45. Cuin A, Massabni AC, Pereira GA, et al. 6-Mercaptopurine complexes with silver and gold ions: anti-tuberculosis and anti-cancer activities. Biomed Pharmacother. 2011;65(5):334-338.
46. Serpe L, Catalano MG, Cavalli R, et al. Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line. Eur J Pharm Biopharm. 2004;58(3):673-680.
47. Ankamwar B, Lai TC, Huang JH, et al. Biocompatibility of Fe3O4 nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cells. Nanotechnology. 2010;21(7):075102.